Watch out, Pfizer and Moderna; Anti-aging breakthrough in mice?; Neuro for the new GSK; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
The Endpoints team will be enjoying a long weekend in observance of Independence Day on Monday. If you’re dedicated enough to be reading this report, don’t miss my colleague Zachary Brennan’s excellent virtual event — a fireside chat followed by a panel — on the post-Covid FDA. You can watch it on-demand here.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 113,500+ biopharma pros reading Endpoints daily — and it's free.